Codexis Inc (STU:4QK)
€ 3.462 0.286 (9.01%) Market Cap: 285.89 Mil Enterprise Value: 241.37 Mil PE Ratio: 0 PB Ratio: 3.87 GF Score: 60/100

Q3 2023 Codexis Inc Earnings Call Transcript

Nov 02, 2023 / 08:30PM GMT
Release Date Price: €1.66 (+11.85%)
Operator

Welcome to Codexis third-quarter 2023 earnings conference call. (Operator Instructions) Please note, this event is being recorded. And now I'll turn the call over to Carrie McKim, Director of Investor Relations. Please go ahead.

Carrie McKim
Codexis, Inc. - IR

Thank you, operator. With me today are Dr. Stephen Dilly, Codexis' President and Chief Executive Officer, Kevin Norrett, Chief Operating Officer, and Sri Ryali, Chief Financial Officer. During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including our guidance for 2023 revenue, product revenues, and gross margin on product revenues as well as our strategies and prospects for revenue growth and successful execution of current and future programs and partnerships, including our ECO Synthesis platform and pharmaceutical manufacturing business.

To the extent that statements contained in this call are not descriptions of historical facts regarding Codexis, they are forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot